De-Risking Clinical Development: Strategic Multipliers in Global Trials

October 28, 2025

  • Article

In today’s demanding clinical development environment—marked by complex protocols, tightened budgets, and heightened scrutiny from regulators, payers, and patients—fragmented trial planning puts capital, credibility, and market opportunity at risk.​

This article explores how scientific, operational, and geographic alignment can act as strategic multipliers to reduce risk and strengthen trial outcomes. It also highlights how Canada’s research ecosystem and programs such as SR&ED and CRIC can offer meaningful financial and regulatory advantages.

⬇️ Download our article to discover how to de-risk clinical trials and gain greater efficiency, diversity, and credibility from the start.